Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NELFCD - LIM homeobox protein cofactor dominant negative form effect on breast cancer cell line
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NELFCD - LIM-only protein 4 induction effect on breast cancer cell line (HG-U133B)
NELFCD - Dioxin effect on breast cancer cell line (HG-U133B)
NELFCD - Cystic fibrosis pathology and 4-phenylbutyrate (HG-U133B)
NELFCD - SMRT depleted breast cancer cell line response to estradiol: time course
NELFCD - Transcription factor p63 inactivation effect on squamous cells (HG-U133B)
NELFCD - Melanoma cell line response to the depletion of various transcription factors and signaling proteins
NELFCD - Epidermal stem cell and transit-amplifying cell (HG-U133B)
NELFCD - Effect of estrogen receptor- or retinoic acid receptor-knockdown on estrogen-sensitive MCF7 breast cancer cells
NELFCD - Androgen receptor modulator effect: time course (HG-U133B)
NELFCD - Zinc finger transcription factor induced fulvestrant resistant MCF7-R73 breast cancer cell lines
NELFCD - Tamoxifen-resistant breast cancer cell line MCF7 subclones
NELFCD - Subcutaneous Interferon-beta-1b treatment in relapsing-remitting multiple sclerosis (U133 B): peripheral mononuclear blood cells
NELFCD - Clinical outcome of stage UICC II colon cancer patients
NELFCD - Polychlorobiphenyl coplanar congener PCB-77 effect on liver cell line
NELFCD - Hypoxia-inducible factor depletion (HG-U133 2.0)
NELFCD - Lysophosphatidic acid effect on breast and prostate cancer cell lines
NELFCD - Argyrin A effect on MCF7 breast cancer cells: time course
NELFCD - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NELFCD - LNCap prostate cancer cell line response to loss of COnstitutive Photomorphogenic-1 and ETV1
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on